TY - JOUR
T1 - Immersive virtual reality in the treatment of auditory hallucinations
T2 - A PRISMA scoping review
AU - Smith, Lisa Charlotte
AU - Mateos, Ana Collados
AU - Due, Anne Sofie
AU - Bergström, Joanna
AU - Nordentoft, Merete
AU - Clemmensen, Lars
AU - Glenthøj, Louise Birkedal
N1 - Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
PY - 2024/4
Y1 - 2024/4
N2 - BACKGROUND: A large group of psychiatric patients suffer from auditory hallucinations (AH) despite relevant treatment regimens. In mental health populations, AH tend to be verbal (AVH) and the content critical or abusive. Trials employing immersive virtual reality (VR) to treat mental health disorders are emerging.OBJECTIVE: The aim of this scoping review is to provide an overview of clinical trials utilizing VR in the treatment of AH and to document knowledge gaps in the literature.METHODS: PubMed, Cochrane Library, and Embase were searched for studies reporting on the use of VR to target AH.RESULTS: 16 papers were included in this PRISMA scoping review (ScR). In most studies VR therapy (VRT) was employed to ameliorate treatment resistant AVH in schizophrenia spectrum disorders. Only two studies included patients with a diagnosis of affective disorders. The VRT was carried out with the use of an avatar to represent the patient's most dominant voice.DISCUSSION: The research field employing VR to treat AH is promising but still in its infancy. Results from larger randomized clinical trials are needed to establish substantial evidence of therapy effectiveness. Additionally, the knowledge base would benefit from more profound qualitative data exploring views of patients and therapists.
AB - BACKGROUND: A large group of psychiatric patients suffer from auditory hallucinations (AH) despite relevant treatment regimens. In mental health populations, AH tend to be verbal (AVH) and the content critical or abusive. Trials employing immersive virtual reality (VR) to treat mental health disorders are emerging.OBJECTIVE: The aim of this scoping review is to provide an overview of clinical trials utilizing VR in the treatment of AH and to document knowledge gaps in the literature.METHODS: PubMed, Cochrane Library, and Embase were searched for studies reporting on the use of VR to target AH.RESULTS: 16 papers were included in this PRISMA scoping review (ScR). In most studies VR therapy (VRT) was employed to ameliorate treatment resistant AVH in schizophrenia spectrum disorders. Only two studies included patients with a diagnosis of affective disorders. The VRT was carried out with the use of an avatar to represent the patient's most dominant voice.DISCUSSION: The research field employing VR to treat AH is promising but still in its infancy. Results from larger randomized clinical trials are needed to establish substantial evidence of therapy effectiveness. Additionally, the knowledge base would benefit from more profound qualitative data exploring views of patients and therapists.
KW - Humans
KW - Hallucinations/therapy
KW - Schizophrenia/complications
KW - Virtual Reality
KW - Therapy, Computer-Assisted/methods
KW - Mental Health
KW - Virtual Reality Exposure Therapy/methods
UR - http://www.scopus.com/inward/record.url?scp=85187023838&partnerID=8YFLogxK
U2 - 10.1016/j.psychres.2024.115834
DO - 10.1016/j.psychres.2024.115834
M3 - Review
C2 - 38452499
SN - 0165-1781
VL - 334
SP - 115834
JO - Psychiatry Research
JF - Psychiatry Research
M1 - 115834
ER -